Ricardo Pereira Mestre
2 clinical trials · Sponsor
◉ Watch Ricardo Pereira Mestre
| Record | Firm | Date |
|---|---|---|
| Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1 (NCT04456049) | Ricardo Pereira Mestre | 2020-08-24 |
Track Ricardo Pereira Mestre automatically
Every clearance here is in the API, with alerts when new ones post.